Literature DB >> 2044226

Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition.

E Muso1, H Yoshida, E Takeuchi, T Shimada, M Yashiro, T Sugiyama, C Kawai.   

Abstract

Molecular size and charge distribution of IgA of sera and glomerular eluates were investigated in ddY mice, spontaneously developing mesangial proliferative glomerulonephritis (GN) with IgA deposition after 40 weeks of age. Serum IgA levels were increased in aged ddY mice more than 40 weeks old with a significant increase (P less than 0.01) at the age of 60 weeks, comparing with those of BALB/c mice. The isoelectric focusing (IEF) spectrotype of pooled serum IgA in 60-week-old mice ranged from 4.2 to 5.5, being similar to those in younger ddY (16 weeks old) and control BALB/c mice (12 weeks old) without enhanced expression of specific IgA peaks. However, IgA in the glomerular eluate from the 60-week-old mice showed limited anionic spectrotypes from pH 4.2 to 4.8. HPLC of IgA in pooled sera and glomerular eluates of 16-, 40- and 60-week-old ddY mice, revealed markedly increased ratios of the dimeric IgA (dIgA) and polymeric IgA (pIgA) in the total IgA with age. In the contrast to serum profiles, monomeric IgA (mIgA) was always detected as the smallest peak of the IgA fractions in glomerular eluates. Furthermore, aged mice with severe GN showed a higher percentage of dIgA and pIgA in total IgA (80%) in the sera than that of the mice with mild GN (64%). HPLC analysis under acid condition of glomerular IgA from 40-week-old ddY mice showed a similar pattern of dIgA and pIgA peaks in neutral buffer without the appearance of mIgA. These findings suggest that there is a selective mechanism for glomerular accumulation of more acid IgA among the polyclonally expanded IgA in old ddY mice, and that the polymeric form of IgA plays a pathogenic role in the development of mesangial proliferative GN in these mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044226      PMCID: PMC1535419     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy.

Authors:  A W van den Wall Bake; M R Daha; J J Haaijman; J Radl; A van der Ark; L A van Es
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

2.  Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge.

Authors:  G R Gallo; T Caulin-Glaser; S N Emancipator; M E Lamm
Journal:  Lab Invest       Date:  1983-03       Impact factor: 5.662

3.  Induction of FcR alpha on murine lymphocytes by IgA in vitro.

Authors:  J Yodoi; M Adachi; T Masuda
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

4.  Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice.

Authors:  G R Gallo; T Caulin-Glaser; M E Lamm
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

5.  IgA-mesangial nephropathy (Berger's disease) with rapid decline in renal function.

Authors:  G D'Amico; F Ferrario; G Colasanti; A Ragni; M Bestetti Bosisio
Journal:  Clin Nephrol       Date:  1981-11       Impact factor: 0.975

6.  Enzyme-linked immunosorbent assay for antibodies to native DNA in sera of patients with SLE.

Authors:  M Kávai; A Bányai; A Zsindely; I Sonkoly; G Szegedi
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

7.  Detection of polymeric IgA in glomeruli from patients with IgA nephropathy.

Authors:  Y Tomino; H Sakai; M Miura; M Endoh; Y Nomoto
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

8.  Isolation and characterization of rat glomerular epithelial cells in vitro.

Authors:  J I Kreisberg; R L Hoover; M J Karnovsky
Journal:  Kidney Int       Date:  1978-07       Impact factor: 10.612

9.  IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.

Authors:  M L Trascasa; J Egido; J Sancho; L Hernando
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

10.  Experimental IgA nephropathy induced by oral immunization.

Authors:  S N Emancipator; G R Gallo; M E Lamm
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.

Authors:  L Layward; A C Allen; S J Harper; J M Hattersley; J Feehally
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

3.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

Review 4.  Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2010-11-06       Impact factor: 2.801

5.  (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.

Authors:  Yayoi Saegusa; Chiharu Sadakane; Junichi Koseki; Yoshihiro Hasegawa; Shoichiro Shindo; Shuichi Takeda; Hiroshi Takeda; Tomohisa Hattori
Journal:  Clin Exp Nephrol       Date:  2010-09-04       Impact factor: 2.801

Review 6.  An evaluation of experimental models of glomerulonephritis.

Authors:  P N Furness; K Harris
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.